Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.
尼达尼布可增强 PD-1 阻断的抗肿瘤疗效，其作用机制可能是抑制髓系来源的抑制细胞和癌症相关成纤维细胞。
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-026-04350-x
Suzuki Ryo, Watanabe Satoshi, Shono Kunihiro, Masuda Takaaki, Yanai Kensuke, Yamazaki Ryo, Ando Yumi, Wakabayashi Tomoya, Tanaka Susumu, Sekiya Tomoki, Kushiro Kohei, Yanagimura Naohiro, Sato Miyuki, Tanaka Tomohiro, Nozaki Koichiro, Saida Yu, Hokari Satoshi, Arita Masashi, Ohashi Riuko, Shima Kenjiro, Kimura Yosuke, Aoki Nobumasa, Ohshima Yasuyoshi, Koya Toshiyuki, Kikuchi Toshiaki
